Regen BioPharma (RGBP) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Regen BioPharma (RGBP) over the last 11 years, with Q4 2025 value amounting to -$4578.0.
- Regen BioPharma's Enterprise Value rose 7437.88% to -$4578.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$4578.0, marking a year-over-year increase of 7437.88%. This contributed to the annual value of -$69555.0 for FY2025, which is 27701.23% down from last year.
- Latest data reveals that Regen BioPharma reported Enterprise Value of -$4578.0 as of Q4 2025, which was up 7437.88% from -$69555.0 recorded in Q3 2025.
- Regen BioPharma's Enterprise Value's 5-year high stood at -$692.0 during Q2 2023, with a 5-year trough of -$727162.0 in Q3 2021.
- In the last 5 years, Regen BioPharma's Enterprise Value had a median value of -$69555.0 in 2025 and averaged -$133400.9.
- Per our database at Business Quant, Regen BioPharma's Enterprise Value soared by 9937.65% in 2023 and then tumbled by 883757.23% in 2024.
- Regen BioPharma's Enterprise Value (Quarter) stood at -$353492.0 in 2021, then surged by 88.47% to -$40741.0 in 2022, then crashed by 205.58% to -$124497.0 in 2023, then soared by 85.65% to -$17868.0 in 2024, then soared by 74.38% to -$4578.0 in 2025.
- Its last three reported values are -$4578.0 in Q4 2025, -$69555.0 for Q3 2025, and -$1761.0 during Q2 2025.